Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Wuxi to Help Develop, Manufacture ADC Candidate in China

19-Jun-2013 - Ambrx and Zhejiang Medicine have selected Wuxi to accelerate the development of a potential ADC (antibody drug conjugate) targeting Her2-positive breast cancer.

Pfizer Selects South African Trial Sites for Partnership Program

19-Jun-2013 - Pfizer has chosen three of Synexus' clinical research centres in South Africa to be a part of its 100-site INSPIRE programme based on the sites’ experience and audit history.

Parexel Backlog May Indicate Future Revenue Boom

18-Jun-2013 - CRO Parexel’s massive backlog could position the company for continued revenue growth moving forward, top executives said at recent conferences.

Chiltern’s Growth Spurs New Expansion, Investments

17-Jun-2013 - Demand is at an all time high according to CRO Chiltern, which reported that its revenue grew more than 16% from the last fiscal year.

inVentiv Seeks to Accelerate Recruitment of Investigators with Partnership

13-Jun-2013 - CRO inVentiv Health has partnered with Medikly to enhance its ability to connect with trial investigators through an online database of physicians.

GSK Pauses Ph I MS Trial and Sacks China R&D Chief

GSK Pauses Ph I MS Trial and Sacks China R&D Chief

12-Jun-2013 - GSK has ‘paused’ a Phase I trial of an MS drug and fired its China R&D chief, Jingwu Zhang, after finding 'manipulated' data in a paper published in Nature Medicine in...

Clinical Research Site Acquisition Signals Shift in Early Development
Updated

Clinical Research Site Acquisition Signals Shift in Early Drug Development

12-Jun-2013 - Altasciences’ purchase of Vince and Associates Clinical Research highlights the industry's shift to conducting more specialized Phase I trials in patients rather than healthy volunteers, experts say.

Covance CEO Confident Growth will Continue Over Next Few Years

12-Jun-2013 - Pharmas' post patent cliff push into new therapeutic areas will mean growth for the CRO industry according to Covance CEO, Joseph Herring.

Quintiles Wins $1M Grant to Compare Uterine Fibroid Treatments

Quintiles Wins $1M Grant to Compare Uterine Fibroid Treatments

12-Jun-2013 - In a rare win for a CRO, Quintiles was awarded a two-year, $1.088M research grant from the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of uterine fibroid treatments.

Professors: EU Data Protection Law Could Make Medical Research Tough

EU Data Protection Amendments Could Make Medical Research Impossible, Professors Say

11-Jun-2013 - Epidemiological and other medical research could be prohibitively difficult to conduct if a new European regulation is passed, according to three professors from the University of Amsterdam.

ChoiceOne Seeks Partners for Asia CRO Business

ChoiceOne Seeks Partners for Asia CRO Business

10-Jun-2013 - UK healthcare services firm ChoiceOne wants EU and US partners to help grow is Asia-focused CRO unit, Choice Pharma.

Private Equity Firms Tempted by PRA

06-Jun-2013 - Three private equity firms could be ready to bid for PRA International, following indications that the US CRO would take Quintiles' lead and go public.

CROs Slowly Shifting to Adaptive Clinical Trial Designs

05-Jun-2013 - As sponsors recognize the value of adaptive clinical trial designs and regulators come on board, CROs are beginning to shift their priorities to be more flexible.

EU Clinical Data Transparency One Step Closer as Draft Regs Approved

03-Jun-2013 - The EU will become more competitive thanks to new clinical trial regulations that include data transparency, says rapporteur Glenis Willmott MEP, though industry is opposed.

Keys for CRO Partnerships: Expertise and Cycle Time Reductions, Expert Says

03-Jun-2013 - Reducing cycle times and leveraging CRO expertise will drive sponsors’ decisions in choosing partners as they look to reduce costs and oversight obligations, according to a new report.

Clinical Investigator Hit with US FDA Warning Letter for Falsified Data

29-May-2013 - The US FDA has sent a warning letter to a clinical investigator after he failed to take adequate action on falsified data in a study he oversaw.

Ethica Picks Alion for Human Research Protection Accreditation

28-May-2013 - Ethica Clinical Research has chosen Alion for accreditation of its Human Research Protection Program (HRPP).

Executives: CROs Need to Be Less ‘Passive’ in Partnerships with Sponsors

27-May-2013 - Pharma and CRO executives have said that CROs could do more to be proactive in their partnerships, though some CRO executives believe that can be difficult because of the varying...

News in brief

ClinTec Pushes into Middle East with Turkish Office

27-May-2013 - CRO ClinTec International will open an office in Istanbul, Turkey to consolidate its presence in the Middle East and North Africa region. 

ACRO Joins Coalition to Rejuvenate Funding for Smaller Research Companies

23-May-2013 - The Association of Clinical Research Organizations (ACRO) has joined a small business coalition as part of its effort to halt the decline of capital into biomedical research.

US House Bill Aims to Expand Release of Clinical Trials Data

21-May-2013 - US House Democrats have re-introduced a bill  that would expand trial data reported by companies to clinicaltrials.gov, but a recent EU court decision shows what kind of resistance should be expected....

Exclusive interview

Quintiles’ Lead Medical Expert: Real World Patient Data Hold Enormous Potential

21-May-2013 - Supplementing prospective randomized, double-blinded clinical trial data with real-world patient data holds “an enormous amount of potential” for CROs and trial sponsors, according to an expert.

News in brief

Harlan Doubles Number of Isolators at Two US Research Facilities

20-May-2013 - CRO Harlan Laboratories has more than doubled the number of isolators at its Indianapolis and Livermore, Calif., research facilities to meet client demand for immunocompromised animal models.

Covance Pushes Further into Biologics Development, Lead Optimization

20-May-2013 - Although preclinical work for CROs has fallen flat in recent quarters, Covance is looking to take advantage of the industry’s shift to early biologic developments and lead optimization.

PRA Prepares to Go Public with Confidential SEC Filing

17-May-2013 - US CRO PRA is proposing to go public again, more than six years since it was taken private, according to a confidential draft registration statement submitted to the US SEC.